Table 1 Clinical and pathological characteristics of 42 TNBC patients.

From: M2 macrophages predict response to neoadjuvant chemotherapy in triple negative breast cancer patients

 

Number/Mean

Percentage/Range

Total cases

42

 

Age

51.8

26–71

Histology type

Invasive ductal carcinoma

40

95.2%

Metaplastic

2

4.8%

Nottingham grade

2.75

2–3

Tubule

2.96

2–3

Nuclear

2.84

2–3

Mitosis

2.32

1–3

HER-2 expression

0–1 + IHC

34

81.0%

2 + IHC

8

19.0%

Neoadjuvant chemotherapy

Non-pCR (residual tumor)

19

45.2%

pCR

23

54.8%

T stage

ypT0

17

40.5%

ypT1

19

45.2%

ypT2

6

14.3%

N stage

  

ypNx

4

9.5%

ypN0

28

66.7%

ypN1

7

16.7%

ypN2

3

7.1%

Back to article page